Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LAMICTAL
- The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children
- Lamotrigine and Bupropion for Meniere's Disease
- Bioequivalence of Lamnet (Lamotrigine)100mg Tablet With the Reference Product Lamictal 100mg (Lamotrigine) Tablet Under Fasting Conditions
- Enhancing the Effects of Alcohol Treatment With Lamotrigine
- A Bioequivalence Study of Two Formulations Lamotrigine 100 mg Tablets and Lamictal 100 mg Tablets in Healthy Adult Volunteers Under Fasting Conditions
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine
- A Bioavailability Crossover Study of Two Formulations of Lamotrigine Extended Release Tablets in Healthy Subjects
- A Trial of Generic Substitution of Antiepileptic Drugs
- Identification of Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression
- BEEP Follow Up: Evaluation of Repeatability of Lamotrigine Pharmacokinetics in Epileptic Patients
- 16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression
- Effect of Lamotrigine on Cognition in NF1
- Study of Lamotrigine to Treat Ménière's Disease
- Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?
- The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mg
- Pregnant Women Taking Lamictal for Bipolar Disorder
- Lamotrigine Bioequivalence
- Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)
- Lamotrigine Extended-Release Tablets 50 mg Under Fed Condition
- Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fasting Condition
- Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed Condition
- Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fasting Condition
- PET and MRI Brain Imaging of Bipolar Disorder
- The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects
- Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder
- Special Drug Use Investigation for LAMICTAL® (Long Term)
- Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
- Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition
- Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fasting Condition
- Sequential Multiple Assignment Treatment for Bipolar Disorder
- Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition
- Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition
- Decision-Making in Bipolar Disorder
- Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents
- Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy
- Special Drug Use Investigation for LAMICTAL Bipolar
- Drug Use Investigation for LAMICTAL
- Reversing Corticosteroid Induced Memory Impairment
- Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fed Condition
- Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fasting Condition
- Lamictal TM, Haloperidol Decanoate in Schizophrenia
- Study of Lamotrigine 2×25 mg IR Tablets of Torrent Pharmaceuticals Limited, India and Lamictal® (Lamotrigine) 2×25 mg Tablets of GlaxoSmithKline, USA, in Healthy Human Adult Subjects, Under Fasting Conditions.
- Study of Lamotrigine 2 x 25 mg IR Tablets of Torrent Pharmaceuticals Pvt., Ltd., India and Lamictal ® (Lamotrigine) 2 x 25 mg Tablets of Glaxo-SmithKline, USA, in Healthy Human Adult Subjects, Under Fed Conditions
- Cognitive Effects of Treatment of Interictal Discharges
- Lamotrigine Augmentation in Resistant Depression
- Lamotrigine Cognitive Function Study in Adult Untreated Epilepsies
- Lamotrigine 25 mg Chewable Tablets, Fasting
- Lamotrigine 25 mg Chewable Tablets, Non-Fasting
- Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions
- Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions
- Determination of Absorption and Elimination of Lamotrigine-XR
- Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients
- Lamotrigine Therapy in Geriatric Bipolar Depression
- Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg
- Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg
- Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder
- Lamotrigine for Symptoms of Geriatric Bipolar Depression
- Pharmacokinetic Study on Raltegravir and Lamotrigine
- An Open-Label Trial Measuring Satisfaction And Convenience Of Two Formulations Of Lamotrigine In Subjects With A Mood Disorder
- Early Detection and Intervention for the Prevention of Psychosis
- Double-Blind Lamictal (Lamotrigine) in Neurotic Excoriation
- GSK Drug Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers
- Lamotrigine Alone Compared to Lamotrigine Plus Antidepressant for the Treatment of Bipolar II Depression
- Lamictal Bipolar Observational Study
- Research Study for Major Depressive Disorder: Investigation of Glutamate Medications
- Clinical Evaluation of BW430C in Epilepsy
- Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
- Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression
- Lamictal in the Treatment of Post-Herpetic Neuralgia
- A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures
- Lamotrigine in Treatment Resistant Depression in Adolescents
- Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
- An Open-Label Study Of Lamictal In Neurotic Excoriation
- Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
- Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI
- A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium
- Lamictal As Add on Treatment in Mixed States of Bipolar Disorder
- Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling
- Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia
- Maintenance Treatment of Bipolar Depression
- Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder
- Lamotrigine Monotherapy in Pediatric Bipolar Disorder
- LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures
- Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
- Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures
- Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
- Acute Treatment of Bipolar II Depression
- Bipolar Study in Adults at Least 18 Years of Age
- Combination Therapy for the Treatment of Bipolar Disorders
- Bipolar Disorder Study for Men and Women
- Pediatric Epilepsy Study in Subjects 1-24 Months
- Pediatric Epilepsy Trial in Subjects 1-24 Months
- New Drugs in the Treatment of Mood Disorders
Clinical trials list
click for details